CP-316819, CAS [[186392-43-8]]

Produktübersicht

• Artikelname: CP-316819, CAS [[186392-43-8]]
• Artikelnummer: MCE-HY-108615
• Hersteller Artikelnummer: HY-108615
• Alternativnummer: MCE-HY-108615-5MG,MCE-HY-108615-10MG,MCE-HY-108615-25MG,MCE-HY-108615-100MG,MCE-HY-108615-50MG,MCE-HY-108615-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: GPi 819

Produktbeschreibung

CP-316819 (GPi 819) is a blood-brain barrier permeable glycogen phosphorylase inhibitor. CP-316819 inhibits hepatic glycogenolysis, safely reduces blood glucose in type 2 diabetes, and rarely induces hypoglycemia. CP-316819 increases brain glycogen reserves, protects neurons, alleviates hypoglycemic brain injury, and inhibits excessive platelet activation, exerting both neuroprotective and vasculoprotective effects. CP-316819 can be used in research related to hypoglycemia, thrombosis, autoimmune inflammatory diseases, and type 2 diabetes[1][2][3][4].

Produkteigenschaften

• Molekulargewicht: 415.87
• Reinheit: 99
• CAS Nummer: [186392-43-8]
• Formel: C21H22ClN3O4
• Target-Kategorie: Phosphorylase

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound